These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 17965318
1. Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: The Hisayama Study. Doi Y, Kubo M, Ninomiya T, Yonemoto K, Iwase M, Arima H, Hata J, Tanizaki Y, Iida M, Kiyohara Y. Diabetes; 2007 Nov; 56(11):2829-33. PubMed ID: 17965318 [Abstract] [Full Text] [Related]
2. The E23K variant in the Kir6.2 subunit of the ATP-sensitive K+ channel does not augment impaired glucose tolerance in Caribbean subjects with a family history of type 2 diabetes. Ezenwaka C, Kalloo R, Uhlig M, Schwenk R, Eckel J. J Endocrinol; 2005 Jun; 185(3):439-44. PubMed ID: 15930170 [Abstract] [Full Text] [Related]
4. Gene-gene interactions between HNF4A and KCNJ11 in predicting Type 2 diabetes in women. Qi L, van Dam RM, Asselbergs FW, Hu FB. Diabet Med; 2007 Nov; 24(11):1187-91. PubMed ID: 17894829 [Abstract] [Full Text] [Related]
6. Genetic study of Saudi diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes. Alsmadi O, Al-Rubeaan K, Wakil SM, Imtiaz F, Mohamed G, Al-Saud H, Al-Saud NA, Aldaghri N, Mohammad S, Meyer BF. Diabetes Metab Res Rev; 2008 Feb; 24(2):137-40. PubMed ID: 17922473 [Abstract] [Full Text] [Related]
7. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Nielsen EM, Hansen L, Carstensen B, Echwald SM, Drivsholm T, Glümer C, Thorsteinsson B, Borch-Johnsen K, Hansen T, Pedersen O. Diabetes; 2003 Feb; 52(2):573-7. PubMed ID: 12540638 [Abstract] [Full Text] [Related]
8. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men. Nordman S, Ding B, Ostenson CG, Kärvestedt L, Brismar K, Efendic S, Gu HF. Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114 [Abstract] [Full Text] [Related]
15. Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians. Vimaleswaran KS, Radha V, Mohan V. Metabolism; 2006 Sep; 55(9):1222-6. PubMed ID: 16919542 [Abstract] [Full Text] [Related]
17. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study. Thorsby PM, Midthjell K, Gjerlaugsen N, Holmen J, Hanssen KF, Birkeland KI, Berg JP. Scand J Clin Lab Invest; 2009 Sep; 69(2):282-7. PubMed ID: 18972257 [Abstract] [Full Text] [Related]
18. KCNJ11 gene E23K variant and therapeutic response to sulfonylureas. Javorsky M, Klimcakova L, Schroner Z, Zidzik J, Babjakova E, Fabianova M, Kozarova M, Tkacova R, Salagovic J, Tkac I. Eur J Intern Med; 2012 Apr; 23(3):245-9. PubMed ID: 22385882 [Abstract] [Full Text] [Related]
19. Kir6.2 variant E23K increases ATP-sensitive K+ channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance. Villareal DT, Koster JC, Robertson H, Akrouh A, Miyake K, Bell GI, Patterson BW, Nichols CG, Polonsky KS. Diabetes; 2009 Aug; 58(8):1869-78. PubMed ID: 19491206 [Abstract] [Full Text] [Related]
20. [Prospective population survey of IGT in a Japanese community, Hisayama]. Kiyohara Y, Fujishima M. Nihon Rinsho; 1996 Oct; 54(10):2755-60. PubMed ID: 8914440 [Abstract] [Full Text] [Related] Page: [Next] [New Search]